Table 3.

MBL codon 54 G > A polymorphism and the risk of gastroduodenal diseases

Genotype	Disease group	Unadjusted OR (95% CI) by univariate analysis	p	Adjusted OR (95% CI) by multivariate analysis	p
G/A (heterozygote)	Hp(+) NAG (n = 49)	0.93 (0.56–1.55)	0.7828	1.02 (0.59–1.75)	0.9466
	Hp(+) mild AG (n = 27)	1.24 (0.66–2.34)	0.5074	1.16 (0.60–2.26)	0.6527
	Hp(+) severe AG (n = 37)	1.38 (0.76–2.52)	0.2937	1.16 (0.61–2.18)	0.6498
	Hp(−) DU(n = 3)	1.23 (0.27–5.66)	0.7938	1.21 (0.26–5.71)	0.8082
	Hp(+) DU (n = 73)	1.19 (0.76–1.85)	0.4450	1.24 (0.78–1.99)	0.3605
	Hp(−) GC(n = 46)	1.16 (0.65–2.04)	0.6170	1.11 (0.61–2.00)	0.7356
	Hp(+) GC (n = 122)	0.85 (0.55–1.31)	0.4566	0.85 (0.54–1.34)	0.7356
A/A (mutant)	Hp(+) NAG (n = 7)	0.95 (0.33–2.74)	0.9255	1.19 (0.39–3.61)	0.7561
	Hp(+) mild AG (n = 5)	0.36 (0.04–2.89)	0.3332	0.33 (0.04–2.81)	0.3126
	Hp(+) severe AG (n = 9)	0.64 (0.13–3.09)	0.5822	0.61 (0.12–3.12)	0.5560
	Hp(−) DU (n = 1)	1.25(0.32–5.88)	0.9521	1.24(0.31–5.77)	0.9434
	Hp(+) DU (n = 14)	0.43 (0.13–1.43)	0.1697	0.45 (0.13–1.55)	0.2031
	Hp(−) GC (n = 7)	1.51 (0.52–4.42)	0.4543	1.93 (0.63–5.89)	0.2484
	Hp(+) GC (n = 27)	0.88 (0.36–2.15)	0.7762	1.10 (0.43–2.79)	0.8496
G/A + A/A (A carrier)	Hp(+) NAG (n = 56)	0.93 (0.57–1.52)	0.7820	1.04 (0.62–1.75)	0.8774
	Hp(+) mild AG (n = 32)	1.12 (0.60–2.09)	0.7239	1.05 (0.55–2.00)	0.8893
	Hp(+) severe AG (n = 46)	1.28 (0.71–2.29)	0.4103	1.09 (0.59–2.01)	0.7929
	Hp(−) DU (n = 4)	1.06 (0.23–4.87)	0.9421	1.06 (0.23–4.98)	0.9386
	Hp(+) DU (n = 87)	1.08 (0.71–1.66)	0.7110	1.13 (0.72–1.78)	0.5868
	Hp(−) GC (n = 53)	1.20 (0.70–2.07)	0.5008	1.19 (0.68–2.09)	0.5480
	Hp(+) GC (n = 149)	0.85 (0.57–1.29)	0.4488	0.88 (0.57–1.35)	0.5528

The control was regarded as the reference subject group, and the G/G wild type was considered as the reference genotype